Medical Specialties Commons^™

Does Beta Amyloid Immunization Reduce Amyloid Plaques And Preserve Cognitive Function In Patients With Alzheimer’S Disease?, Andrea Sasin

PCOM Physician Assistant Studies Student Scholarship

Objective: The objective of this systematic review is to examine the efficacy of beta amyloid immunization in reducing amyloid plaques and preserving cognitive function in patients with Alzheimer’s disease (AD).

Mitochondria-Centric Activation Induced Cell Death Of Cytolytic T Lymphocytes And Its Implications For Cancer Immunotherapy, Arvind Chhabra

UCHC Articles - Research

Premature death of the adoptively transferred cytolytic T lymphocytes (CTL) by means of activation induced cell death (AICD) represents one of the major constraints in devising an effective anti-cancer immune intervention strategy. Understanding the mechanism of AICD is, therefore, critical for developing methods to interfere with this death process. Although the existing paradigm on AICD centers around the initiation of the cascade of events originating from the engagement of death receptors leading to the activation of effector caspases and eventually resulting in cell death, recent findings have questioned the universal role of caspases as the cell death executioners. We here …

Oncolog Volume 55, Number 03, March 2010, Bryan Tutt, Joe Munch

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• Benign Tumors That Cause Big Problems:Fortunately, parathyroid tumors can be removed with minimally invasive surgery.
• Preventing Bone Loss nad Fractures in Cancer Patients
• INBRIEF: Leukemia Cells Observed Burning Fat to Evade Death/Assesment Tool Takes Aim at Graft-versus-Host Disease
• House call: Immunotherapy:Boosting the Body's Fight Against Cancer

Oncolog Volume 51, Number 02, February 2006, Sunni Hosemann, Ellen Mcdonald Phd

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• Emergency Care for Cancer Patients
• Bringing Clinical Trials to the Community
• House Call: Understanding the Immune System
• DiaLog: Cognitive Dysfunction in Cancer, by Christina Meyers, PhD, Professor and Chief, Section of Neuropsychology

Oncolog, Volume 52, Number 03, March 2007, Sunni Hosemann, Karen Stuyck, Elizabeth L. Travis Phd

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• New Approaches for Advanced Melanoma
• Helping Patients Stop Smoking
• House Call: Simple Skin Cancer Prevention
• DiaLog: Toward Gender Equity in Academic Medicine, by Elizabeth Travis, PhD, Associate Vice President, Women Faculty Programs

Evaluation Of Toxicity Following Electrically Mediated Interleukin-12 Gene Delivery In A B16 Mouse Melanoma Model, Loree Heller, Kathleen Merkler, Jeffrey Westover, Yolmari Cruz, Domenico Coppola, Kaaron Benson, Adil Daud, Richard Heller

Bioelectrics Publications

PURPOSE: Interleukin-12 (IL-12) has potential as an immunotherapeutic agent for the treatment of cancer but is unfortunately associated with toxicity. Delivery of a plasmid encoding IL-12 with electroporation induces an antitumor effect in the B16 mouse melanoma model without serious side effects. To translate this observation to the clinic, an evaluation of toxicity was done in the mouse model.

EXPERIMENTAL DESIGN: Weight change, tumor response, blood chemistry and hematology values, and serum IL-12 levels were evaluated. Multiple tissues were analyzed histopathologically.

RESULTS: A pronounced reduction in tumor volume, including a large percentage of complete regressions, was observed after electrically mediated …

Oncolog Volume 51, Number 05, May 2006, Sunni Hosemann, Kathryn Carnes, Patrick Hwu Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• A Better Kind of Brain Surgery
• Raloxifene Effective for Breast Cancer Prevention
• House Call: The Many Benefits of Massage
• DiaLog: Cancer Vaccines and Immunotherapy, by Patrick Hwu, MD, Professor and Chair, Melanoma Medical Oncology

Oncolog, Volume 50, Number 04, April 2005, Rachel Williams, Ellen Mcdonald, Michael Fisch Md, Mph

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• Harnessing the Immune System: The Promise and Potential of Cancer Vaccines
• Considering Prophylactic Surgery
• House Call: Chemotherapy and Hair Loss
• DiaLog: Redefining Success in Cancer Care, by Michael Fisch, MD, MPH, Medical Director, Community Clinical Oncology Program

Oncolog, Volume 48, Number 12, December 2003, Karen Stuyck, Dawn Chalaire, Martha A. Askins, Martha Aschenbrenner

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• On the Move: Efforts Under Way to Improve Outcomes for Patients with Renal Cancer
• Protocols: Studies Examine Treatments for Renal Cell Carcinoma
• Art Therapy Helps Children Affected by Cancer Express Their Emotions
• Children's Art Project Has Been Improving the Lives of Children with Cancer for 30 Years
• DiaLog: When a Parent Is Sick: Talking to Children about Cancer, by Martha A. Askins, PhD, Division of Pediatrics, and Martha Aschenbrenner, Director, Child Life Services

Synergistic Interactions Of Chlorambucil, Dha, And Trail In Jurkat And H460 Human Cancer Cells, Jennifer Ellen Bush-O'Donnell

Theses, Dissertations and Capstones

Traditional chemotherapeutic drugs are prone to toxicity and may result in secondary cancers. In recent years much attention has been garnered by alternate methods of cancer treatment with fewer side effects, including immunotherapy and administration of ω-3 fatty acids, both of which have been shown to cause apoptosis in cancer cells. Docosahexaenoic acid (DHA), a fatty acid, is a normal component of cell membranes and is safe for systemic administration. The cytokine TRAIL (tumor necrosis factorrelated apoptosis-inducing ligand) is able to induce apoptosis in cancer cells while sparing normal tissue. In this study, the alkylating agent chlorambucil (CLB) was combined …

Oncolog, Volume 47, Number 04, April 2002, Beth Notzon, Karen Stuyck, Felipe Samaniego Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• Researchers Focus on Bioimmunotherap for Treatment of Non-Hodgkin's Lymphomas
• Protocols: Non-Hodgkin's Lymphoma Studies
• House Call: The First Cancer Prevention Vaccine
• DiaLog: The Viral Origins of Lymphomas, by Felipe Samaniego, MD, Assistant Professor, Department of Lymphoma and Myeloma
• Research Consortium Recruiting Volunteers to Study the Role of Genetics in Cancer Development and Patient Care

Oncolog, Volume 45, Number 09, September 2000, Mariann Crapanzano, Kerry L. Wright, David L. Callender Md

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• Multidisciplinary Care Improves Treatment, Enhances Quality of Life for Patients with Colorectal Cancer
• DiaLog: Treating Cancer with a Team Approach, by David L. Callender, MD, Senior Vice President and Chief Medical Officer
• Cervical Cancer Prevention: Could Spectroscopy Steal the Spot"light"?
• Virtual Colonoscopy a Potential Screening Reality
• Protocols: Clinical Trials for Colorectal Cancer
• Compass: Clinical Practice Guidelines
• House Call: Sharing Personal Stories: Books Written by People with Cancer

Oncolog, Volume 44, Number 03, March 1999, Dawn Chalaire, Beth W. Allen, Alison Ruffin

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• Vaccines, Other New Options Expand Renal Cancer Therapy Program
• Thirteen-story Alkek Hospital Makes Debut
• Training Takes Prevention and Early Detection Worldwide
• Nephrectomy Before or After Systemic Therapy­--That Is the Question
• House Call: Alcohol and Cancer: Making Sense of a Cocktail of Risks and Benefits
• Protocols: Renal Cell Carcinoma Trials Offer Therapies for Treated and Untreated Patients
• Compass: New Quarterly Supplement Offers Perspectives on Clinical Guidelines

Oncolog, Volume 40, Number 03, July-September 1995, Kathryn L. Hale, Vickie` J. Williams, Sunita Patterson

OncoLog MD Anderson's Report to Physicians (All issues) Archives

• M. D. Anderson leads the fight against bone pain from metastatic cancer
• New computer program enhances the surgeon-patient consultation
• Bladder cancer: molecular markers may guide treatment

Newsletter, Volume 24, Number 02, March - April 1979, Luis A. Desantos Md, Adilson Prando Md, Emil J. Freireich Md

Newsletter: A Report to Physicians of Texas Archives

• Synovial Hyperemia in Giant Cell Tumors of Bone, Luis A. DeSantos, MD, and Adilson Prando, MD
• Linus Pauling speaks at MDAH
• Medical Oncology Course Offered
• Ethical Considerations in the Treatment of Cancer Patients, Emil J. Freireich, MD.
• Follow-up Report: Carcinogenic Inhibition by Wheat Extracts
• Laser Microsurgery Technique Available
• Book on Hematologic Malignancies Published
• Nutritionist develop Video Presentations

Newsletter, Volume 23, Number 04, July - August 1978, Steven J. Culbert Md, Chiu-Nan Lai Phd, Joseph Sinkovics Md, Carl Plager Md

Newsletter: A Report to Physicians of Texas Archives

• Dr Clark Retires
• Nuclear Fallout Effects in the Marshall Islands, Steven J. Culbert, MD
• Newsletter Mailing List Conversion
• Metabolic Activation of Carcinogens Inhibited by Wheat Extracts, Chiu-Nan Lai, PhD
• Upton Speaks at Science Park Dedication
• Solid Tumor Service Activities
• Distinguished Service Awards
• Chemotherapy-Induced Stomatitis and Periodontal Disease

Newsletter, Volume 23, Number 01, January - February 1978, Aman U. Buzdar Md, Victorio Rodriguez Md

Newsletter: A Report to Physicians of Texas Archives

• CIDAC Established at MDAH
• Breast Cancer Adjuvant Chemoimmunotherapy, Aman U. Buzdar, MD
• Dr. Jackson Appointed to Institute of Medicine
• Hill Award and Russell Lectureship Presented
• Twenty-Second Clinical Conference Held
• Radiotherapist Receives Gold Medal
• Kilgo Memorial Fountain Dedicated
• Acute Infections in Cancer Patients, Victorio Rodriquez, MD
• Antimicrobial Agents for Treatment of Infections in cancer Patients
• Twelfth Annual Heath Award Presented
• Dr. Gallager elected to ACR
• MDAH Referral Guide

Newsletter, Volume 22, Number 04, July - August 1977

Newsletter: A Report to Physicians of Texas Archives

• Public Screening for Oral Cancer
• The Anderson Mayfair
• Dr. Becker Elected to Council
• The Pharmacy Department
• Twenty-Second Annual Clinical Conference - Immunotherapy of Human Cancer
• American College of Nutrition

Newsletter, Volume 18, Number 03, August 1973

Newsletter: A Report to Physicians of Texas Archives

• Shivers Dedicates Rehab Annex
• Immunological Aspects of Neoplasia Spotlighted at 26th Annual Symposium
• Summer Science Students Report Research
• Dr. Derrick Receives Award
• Blumenschein Named Assistant Director
• Anderson breaks Ground for Hospital
• 18th Clinical Conference Set for November 8-10 – Diagnosis Emphasized
• New Staff